NVCR logo

NovoCure Limited (NVCR) Cash From Operations

Annual CFO

-$26.37 M
+$46.97 M+64.04%

December 31, 2024

Summary

Performance

1-Year Change

+64.04%

3-Year Change

-131.86%

5-Year Change

-199.06%

15-Year Change

+20.42%

NVCR Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.62%
NVCR annual cash flow from operations is higher than 39.62% of companies in Healthcare sector

High & Low

All-time High

$99.15 M
NVCR annual cash flow from operations is currently -126.60% below its historical high of $99.15 million

3-Year Low

-$73.34 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
NVCR previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
NVCR next annual earnings announcement has not yet been scheduled

OtherNVCRcash flowmetrics:

Annual CFI

-$140.24 M
NVCR annual cash flow from investing activities is -$140.24 million

Annual CFF

$90.31 M
NVCR annual cash flow from financing activities is $90.31 million

Annual FCF

-$69.22 M
NVCR annual free cash flow is -$69.22 million

Annual CAPEX

$42.85 M
NVCR annual capital expenditures is $42.85 million

Quarterly CFO

-$3.45 M
-$13.83 M-133.26%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-123.96%

5-Year Change

-149.57%

NVCR Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

51.15%
NVCR quarterly cash flow from operations is higher than 51.15% of companies in Healthcare sector

High & Low

All-time High

$53.48 M
NVCR quarterly cash flow from operations is currently -106.45% below its historical high of $53.48 million

3-Year Low

-$31.57 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVCR previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
NVCR next earnings announcement is scheduled for May 2, 2025

OtherNVCRcash flowmetrics:

Quarterly CFI

-$22.21 M
NVCR quarterly cash flow from investing activities is -$22.21 million

Quarterly CFF

$2.69 M
NVCR quarterly cash flow from financing activities is $2.69 million

Quarterly FCF

-$12.39 M
NVCR quarterly free cash flow is -$12.39 million

Quarterly CAPEX

$8.94 M
NVCR quarterly capital expenditures is $8.94 million

TTM CFO

-$26.37 M
+$11.11 M+29.64%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-131.86%

5-Year Change

-199.06%

NVCR TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.22%
NVCR TTM cash flow from operations is higher than 39.22% of companies in Healthcare sector

High & Low

All-time High

$128.40 M
NVCR TTM cash flow from operations is currently -120.54% below its historical high of $128.40 million

3-Year Low

-$88.18 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVCR previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 2, 2025
NVCR next earnings announcement is scheduled for May 2, 2025

OtherNVCRcash flowmetrics:

TTM CFI

-$140.24 M
NVCR TTM cash flow from investing activities is -$140.24 million

TTM CFF

$90.31 M
NVCR TTM cash flow from financing activities is $90.31 million

TTM FCF

-$69.22 M
NVCR TTM free cash flow is -$69.22 million

TTM CAPEX

$42.85 M
NVCR TTM capital expenditures is $42.85 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

NVCR Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+64.0%0.0%0.0%
3 y3 years-131.9%-124.0%-131.9%
5 y5 years-199.1%-149.6%-199.1%

NVCR Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-131.9%+64.0%-115.4%+89.1%-131.9%+70.1%
5 y5-year-126.6%+64.0%-106.5%+89.1%-120.5%+70.1%
alltimeall time-126.6%+75.5%-106.5%+89.7%-120.5%+78.0%

NovoCure Limited Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$26.37 M(-64.0%)
-$3.45 M(-133.3%)
-$26.37 M(-29.6%)
Sep 2024
-
$10.38 M(-703.3%)
-$37.48 M(-44.2%)
Jun 2024
-
-$1.72 M(-94.6%)
-$67.17 M(-23.8%)
Mar 2024
-
-$31.57 M(+116.9%)
-$88.18 M(+20.2%)
Dec 2023
-$73.34 M(-338.2%)
-$14.56 M(-24.6%)
-$73.34 M(+17.4%)
Sep 2023
-
-$19.31 M(-15.1%)
-$62.48 M(+201.1%)
Jun 2023
-
-$22.74 M(+35.9%)
-$20.75 M(-216.9%)
Mar 2023
-
-$16.73 M(+351.2%)
$17.75 M(-42.4%)
Dec 2022
$30.79 M(-62.8%)
-$3.71 M(-116.5%)
$30.79 M(-37.0%)
Sep 2022
-
$22.42 M(+42.2%)
$48.90 M(-3.9%)
Jun 2022
-
$15.76 M(-527.5%)
$50.88 M(-17.0%)
Mar 2022
-
-$3.69 M(-125.6%)
$61.29 M(-25.9%)
Dec 2021
$82.76 M(-16.5%)
$14.40 M(-41.0%)
$82.76 M(-32.1%)
Sep 2021
-
$24.40 M(-6.8%)
$121.83 M(-5.1%)
Jun 2021
-
$26.17 M(+47.2%)
$128.40 M(+11.7%)
Mar 2021
-
$17.78 M(-66.8%)
$114.97 M(+16.0%)
Dec 2020
$99.15 M(+272.5%)
$53.48 M(+72.7%)
$99.15 M(+88.4%)
Sep 2020
-
$30.97 M(+143.1%)
$52.63 M(+43.9%)
Jun 2020
-
$12.74 M(+551.0%)
$36.57 M(+11.2%)
Mar 2020
-
$1.96 M(-71.9%)
$32.89 M(+23.6%)
Dec 2019
$26.62 M
$6.96 M(-53.3%)
$26.62 M(-27.0%)
DateAnnualQuarterlyTTM
Sep 2019
-
$14.91 M(+64.4%)
$36.47 M(+34.1%)
Jun 2019
-
$9.07 M(-310.1%)
$27.20 M(+155.6%)
Mar 2019
-
-$4.32 M(-125.7%)
$10.64 M(-670.7%)
Dec 2018
-$1.86 M(-94.4%)
$16.81 M(+198.2%)
-$1.86 M(-91.4%)
Sep 2018
-
$5.64 M(-175.2%)
-$21.58 M(-12.5%)
Jun 2018
-
-$7.49 M(-55.5%)
-$24.67 M(+7.0%)
Mar 2018
-
-$16.82 M(+480.5%)
-$23.05 M(-30.4%)
Dec 2017
-$33.13 M(-69.2%)
-$2.90 M(-213.7%)
-$33.13 M(-24.6%)
Sep 2017
-
$2.55 M(-143.4%)
-$43.96 M(-45.1%)
Jun 2017
-
-$5.88 M(-78.2%)
-$80.00 M(-22.7%)
Mar 2017
-
-$26.91 M(+96.1%)
-$103.52 M(-3.8%)
Dec 2016
-$107.59 M(+7.7%)
-$13.72 M(-59.0%)
-$107.59 M(-10.3%)
Sep 2016
-
-$33.50 M(+14.0%)
-$119.99 M(+10.5%)
Jun 2016
-
-$29.39 M(-5.1%)
-$108.60 M(+6.1%)
Mar 2016
-
-$30.98 M(+18.6%)
-$102.39 M(+2.5%)
Dec 2015
-$99.88 M(+34.5%)
-$26.12 M(+18.2%)
-$99.88 M(+35.4%)
Sep 2015
-
-$22.11 M(-4.7%)
-$73.76 M(+42.8%)
Jun 2015
-
-$23.19 M(-18.5%)
-$51.66 M(+81.5%)
Mar 2015
-
-$28.47 M
-$28.47 M
Dec 2014
-$74.24 M(+40.8%)
-
-
Dec 2013
-$52.72 M
-
-

FAQ

  • What is NovoCure Limited annual cash flow from operations?
  • What is the all time high annual CFO for NovoCure Limited?
  • What is NovoCure Limited annual CFO year-on-year change?
  • What is NovoCure Limited quarterly cash flow from operations?
  • What is the all time high quarterly CFO for NovoCure Limited?
  • What is NovoCure Limited quarterly CFO year-on-year change?
  • What is NovoCure Limited TTM cash flow from operations?
  • What is the all time high TTM CFO for NovoCure Limited?
  • What is NovoCure Limited TTM CFO year-on-year change?

What is NovoCure Limited annual cash flow from operations?

The current annual CFO of NVCR is -$26.37 M

What is the all time high annual CFO for NovoCure Limited?

NovoCure Limited all-time high annual cash flow from operations is $99.15 M

What is NovoCure Limited annual CFO year-on-year change?

Over the past year, NVCR annual cash flow from operations has changed by +$46.97 M (+64.04%)

What is NovoCure Limited quarterly cash flow from operations?

The current quarterly CFO of NVCR is -$3.45 M

What is the all time high quarterly CFO for NovoCure Limited?

NovoCure Limited all-time high quarterly cash flow from operations is $53.48 M

What is NovoCure Limited quarterly CFO year-on-year change?

Over the past year, NVCR quarterly cash flow from operations has changed by $0.00 (0.00%)

What is NovoCure Limited TTM cash flow from operations?

The current TTM CFO of NVCR is -$26.37 M

What is the all time high TTM CFO for NovoCure Limited?

NovoCure Limited all-time high TTM cash flow from operations is $128.40 M

What is NovoCure Limited TTM CFO year-on-year change?

Over the past year, NVCR TTM cash flow from operations has changed by $0.00 (0.00%)